Moise Alexander, Abdulhaleem Mawaddah, Bandargal Saruchi, Daniela da Silva Sabrina, Payne Richard J, Forest Veronique-Isabelle
Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
Department of Otolaryngology-Head and Neck Surgery, Jewish General Hospital, Montreal, Canada.
J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241304366. doi: 10.1177/19160216241304366.
Minimally invasive parathyroidectomy (MIP) in patients with a parathyroid adenoma (PA) requires imaging modalities for precise localization. Parathyroid hormone assay on ultrasound-guided fine-needle aspiration washout, or PTH washout, can be used for this purpose. It is unclear whether PTH washout complements traditional PA localization techniques such as a sestamibi (MIBI) scan or diminishes its need. This study aims to determine whether a positive PTH washout obviates the need for an MIBI scan in the preoperative localization of a PA.
A multi-center retrospective, comparative review comprised adult patients who underwent MIP at 2 McGill University teaching hospitals between 2018 and 2022. Patients who had both PTH washout and MIBI scan for preoperative localization of PA, final histopathology reports available, and preoperative/postoperative results recorded were included in the final analysis.
Of the 193 patients' charts reviewed, 87 were included in this study. Of these 87 patients, 74.7% (65/87) had a positive PTH washout result. Among those, MIBI correctly detected 90.8% (59/65) of the PAs. The MIBI scan did not contribute meaningful information for any of the 65 patients who had positive PTH washout results.
These findings strongly support the use of preoperative dedicated ultrasound as the initial standard procedure. When a PA candidate on ultrasound is found, a PTH washout should be performed. If positive, it could suffice as the sole localization method for MIP surgery. When a PA was identified on ultrasound and confirmed with PTH washout, the MIBI scan did not add more information. Benefits include fewer patient tests, less exposure to ionizing radiation, and reduced healthcare expenses.
对于甲状旁腺腺瘤(PA)患者,微创甲状旁腺切除术(MIP)需要成像方式进行精确定位。超声引导下细针穿刺冲洗液中的甲状旁腺激素检测,即PTH冲洗液检测,可用于此目的。目前尚不清楚PTH冲洗液检测是补充了传统的PA定位技术,如锝[99mTc]甲氧基异丁基异腈(MIBI)扫描,还是减少了对其的需求。本研究旨在确定PTH冲洗液检测结果为阳性时,是否可避免在PA术前定位中进行MIBI扫描。
一项多中心回顾性比较研究,纳入2018年至2022年期间在2家麦吉尔大学教学医院接受MIP的成年患者。对术前进行PA定位时同时进行了PTH冲洗液检测和MIBI扫描、有最终组织病理学报告且记录了术前/术后结果的患者进行最终分析。
在审查的193例患者病历中,87例纳入本研究。在这87例患者中,74.7%(65/87)的PTH冲洗液检测结果为阳性。其中,MIBI正确检测出90.8%(59/65)的PA。对于65例PTH冲洗液检测结果为阳性的患者,MIBI扫描均未提供有意义的信息。
这些发现有力地支持将术前专用超声作为初始标准程序。当超声检查发现PA候选者时,应进行PTH冲洗液检测。如果结果为阳性,它可作为MIP手术的唯一定位方法。当超声检查发现PA并经PTH冲洗液检测确认时,MIBI扫描并未提供更多信息。其益处包括减少患者检查、减少电离辐射暴露以及降低医疗费用。